BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6285723)

  • 21. Virus drug-resistance: mechanisms and consequences.
    Larder BA; Darby G
    Antiviral Res; 1984 Apr; 4(1-2):1-42. PubMed ID: 6331303
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
    Larder BA; Derse D; Cheng YC; Darby G
    J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of non-temperature-sensitive genes on the genetic map of herpes simplex virus type 1.
    Brown SM; Jamieson AT
    IARC Sci Publ (1971); 1978; (24 Pt 1):33-9. PubMed ID: 221337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
    Darby G; Churcher MJ; Larder BA
    J Virol; 1984 Jun; 50(3):838-46. PubMed ID: 6328014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
    Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract]   [Full Text] [Related]  

  • 27. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of resistance of herpes simplex virus to acyclovir.
    Crumpacker CS
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):190-5. PubMed ID: 2828441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir-resistant herpes simplex virus.
    N Engl J Med; 1982 Sep; 307(11):681-2. PubMed ID: 6287259
    [No Abstract]   [Full Text] [Related]  

  • 32. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.
    Griffiths A; Coen DM
    J Virol; 2003 Feb; 77(3):2282-6. PubMed ID: 12525666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
    Biron KK; Fyfe JA; Noblin JE; Elion GB
    Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A perspective on resistance to acyclovir in herpes simplex virus.
    Field HJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():129-35. PubMed ID: 6313592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation within the herpes simplex virus DNA polymerase gene conferring resistance to (R)-9-(3,4-dihydroxybutyl)guanine.
    Chiou HC; Kerns KM; Coen DM
    Antimicrob Agents Chemother; 1986 Sep; 30(3):502-4. PubMed ID: 3022642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General aspects of virus drug resistance with special reference to herpes simplex virus.
    Coen DM
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():1-10. PubMed ID: 3025148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.
    Crumpacker CS; Kowalsky PN; Oliver SA; Schnipper LE; Field AK
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1556-60. PubMed ID: 6324203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.